Therefore, the dramatic increase of H3K27ac activity at ETS2-SE region and its strong correlation with the upregulation of ETS2 mRNA level in primary CRC samples substantially support the hypothesis that gain of enhancer activity represents a major contributor to ETS2 activation in CRC pathogenesis. This evidence concerns the gene ETS2 and colorectal carcinoma.